The postoperative analgesia effect of Ultrasound-guided Serratus anterior plane block combined ropivacaine with Dexmedetomidine on patients undergoing Thoracoscopic surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040247

Enrollment

Unknown

Registered

2020-11-26

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Group C:20ml 0.5% ropivacaine

Group RD1:20ml 0.5% ropivacaine combined with 0.5 ug / kg dexmedetomidine

Group RD2:20ml 0.5% ropivacaine combined with 1 ug / kg dexmedetomidine

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40 to 65 years old; 2. American Society of anesthesiologists (ASA) was classified as grade 1 to level 3; 3. general anesthesia combined with anterior serratus nerve block during operation.

Exclusion criteria

Exclusion criteria: 1. Chronic renal failure (glomerular filtration rate 30 kg/m2); 6. allergy to drugs used in the study; 7. operation time 3 h.

Design outcomes

Primary

Measure	Time frame
Postoperative sufentanil consumption;Pain score;	—

Secondary

Measure	Time frame
Hemodynamics;Functional activity score;Level of Sedation;Bruggrmann comfort scale;Demand for narcotic and vasoactive drugs;Length of stay and hospital stay in PACU;Patient and surgeon satisfaction score;Incidence of postoperative chronic pain;	—

Contacts

Public ContactDeqian Xin

YANTAI YUHUANGDING HOSPITAL

784253489@qq.com+86 15098646876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026